| [1] |
Wirdefeldt K, Adami HO, Cole P，et al.Epidemiology and etiology of Parkinson′s disease：a review of the evidence[J]．Eur J Epidemiol，2011，26(Suppl1):S1-S58.
|
| [2] |
Hirtz D, Thurman DJ, Gwinn-Hardy K，et al.How common are the " common" neurologic disorders[J]．Neurology，2007，68(5):326-337.
|
| [3] |
中华医学会神经病学分会帕金森病及运动障碍学组．中国帕金森病治疗指南(第三版)[J]．中华神经科杂志，2014，47(6):428-433.
|
| [4] |
刘疏影，陈彪．帕金森病流行现状[J]．中国现代神经疾病杂志，2016，16(2):98-101.
|
| [5] |
Sharma S, Moon CS, Khogali A，et al.Biomarkers in Parkinson′s disease (recent update)[J]．Neurochem Int，2013，63(3):201-229.
|
| [6] |
Pan S, Shi M, Jin J，et al.Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer[J]．Mol Cell Proteomics，2007，6(10):1818-1823.
|
| [7] |
Fountoulakis M, Hardmeier R, Hoger H，et al.Postmortem changes in the level of brain proteins[J]．Exp Neurol，2001，167(1):86-94.
|
| [8] |
Licker V, Kovari E, Hochstrasser DF，et al.Proteomics in human Parkinson′s disease research[J]．J Proteomics，2009，73(1):10-29.
|
| [9] |
Basso M, Giraudo S, Corpillo D，et al.Proteome analysis of human substantia nigra in Parkinson's disease[J]．Proteomics，2004，4(12):3943-3952.
|
| [10] |
Werner CJ, Heyny-von Haussen R, Mall G，et al.Proteome analysis of human substantia nigra in Parkinson's disease[J]．Proteome Sci，2008 (6):8.
|
| [11] |
Shi M, Jin J, Wang Y, et al. Mortalin：a protein associated with progression of parkinson disease? [J]．J Neuropathol Exp Neurol，2008，67(2):117-124.
|
| [12] |
陈涛，唐北沙，廖小平．α-突触核蛋白在帕金森病发病机制中的作用[J]．中国神经科杂志，2006，39(6):415-418.
|
| [13] |
徐丽，曹学兵，孙圣刚，等．鱼藤酮诱导细胞内泛素化α-synuclein聚集选择性损伤多巴胺神经元[J]．中国神经免疫学和神经病学杂志，2007(1):35-39.
|
| [14] |
Andersen AD, Binzer M, Stenager E, et al. Cerebrospinal fluid biomarkers for Parkinson′s disease－a systematic review[J]．Acta Neurol Scand，2017，135(1):34-56.
|
| [15] |
Sinha A, Srivastava N, Singh S，et al.Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson′s disease patients：a proteomic approach[J]．Clin Chim Acta，2009，400(1/2):14-20.
|
| [16] |
Zhang X, Yin X, Yu H，et al.Quantitative proteomic analysis of serum proteins in patients with Parkinson′s disease using an isobaric tag for relative and absolute quantification labeling，two-dimensional liquid chromatography，and tandem mass spectrometry[J]．Analyst，2012，137(2):490-495.
|
| [17] |
Hong Z, Shi M, Chung KA, et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of parkinson′s disease[J]．Brain，2010，133(3):713-726.
|
| [18] |
Bonifati V, Rizzu P, Squitieri F，et al.DJ-1(PARK7)，a novel gene for autosomal recessive，early onset parkinsonism[J]．Neurol Sci，2003，24(3):159-160.
|
| [19] |
Taira T, Saito Y, Niki T，et al.DJ-1 has a role in antioxidative stress to prevent cell death[J]．EMBO Rep，2004，5(2):213-218.
|
| [20] |
Shi M, Zabetian CP, Hancock AM，et al.Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease[J]．Neurosci Lett，2010，480(1):78-82.
|
| [21] |
Sowell RA, Owen JB, Butterfield DA.Proteomics in animal models of Alzheimer′s and Parkinson′s diseases[J]．Ageing Res Rev，2009，8(1):1-17.
|
| [22] |
Waxman EA, Giasson BI.Molecular mechanisms of alpha-synuclein neurodegeneration[J]．Biochim Biophys Acta，2009，1792(7):616-624.
|
| [23] |
Valastro B, Dekundy A, Krogh M，et al.Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia[J]．J Neurochem，2007，102(4):1395-1409.
|
| [24] |
Dawson TM, Dawson VL.Molecular pathways of neurodegeneration in parkinson's disease[J]．Science，2003，302(5646):819-822.
|
| [25] |
Skold K, Svensson M, Nilsson A，et al.Decreased striatal levels of PEP-19 following MPTP lesion in the mouse[J]．J Proteome Res，2006，5(2):262-269.
|
| [26] |
Putkey JA, Kleerekoper Q, Gaertner TR，et al.A new role for IQ motif proteins in regulating calmodulin function[J]．J Biol Chem，2003，278(50):49667-49670.
|
| [27] |
McLaughlin P, Zhou Y, Ma T，et al.Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity[J]．Glia，2006，53(6):567-582.
|